Association between fasting plasma glucose and high-sensitivity C-reactive protein: Gender differences in a Japanese community-dwelling population

Cardiovascular Diabetology

Volumn 10, Issue , 2011, Pages

  Kawamoto, Ryuichi ^a,b   Tabara, Yasuharu ^a   Kohara, Katsuhiko ^a   Miki, Tetsuro ^a   Kusunoki, Tomo ^a,b   Takayama, Shuzo ^a   Abe, Masanori ^a   Katoh, Tateaki ^b   Ohtsuka, Nobuyuki ^b  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Seiyo Municipal Nomura Hospital   (Japan)

Author keywords

C reactive protein; Fasting plasma glucose; Gender interaction; Risk factor; Type 2 diabetes

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; URIC ACID; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; COMMUNITY; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INFLAMMATION; JAPANESE; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MULTIPLE REGRESSION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PLASMA; RISK FACTOR; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; URIC ACID BLOOD LEVEL; BLOOD; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DIET RESTRICTION; ETHNOLOGY; INFORMATION PROCESSING; JAPAN; METABOLISM; MIDDLE AGED; SEXUAL DEVELOPMENT; STATISTICAL MODEL;

AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; DATA COLLECTION; FASTING; FEMALE; HUMANS; INFLAMMATION; JAPAN; LINEAR MODELS; MALE; MIDDLE AGED; RISK FACTORS; SEX CHARACTERISTICS;

EID: 79958172814     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-10-51     Document Type: Article

References (35)

1. Ford ES. The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count: findings from the Third National Health and Nutrition Examination Survey. Atherosclerosis 2003, 168:351-358. 10.1016/S0021-9150(03)00134-5, 12801619.
2. Tomiyama H, Koji Y, Yambe M, Motobe K, Shiina K, Gulnisa Z, Yamamoto Y, Yamashina A. Elevated C-reactive protein augments increased arterial stiffness in subjects with the metabolic syndrome. Hypertension 2005, 45:997-1003. 10.1161/01.HYP.0000165018.63523.8a, 15837828.
3. Sabanayagam C, Shankar A, Lim SC, Lee J, Tai ES, Wong TY. Serum C-reactive protein level and prediabetes in two Asian populations. Diabetologia 2011, 54:767-775. 10.1007/s00125-011-2052-5, 21267537.
4. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998, 98:731-733.
5. Anan F, Masaki T, Kikuchi H, Iwao T, Shimomura T, Umeno Y, Eshima N, Saikawa T, Yoshimatsu H. Association between plasma high-sensitivity C-reactive protein and insulin resistance and white matter lesions in Japanese type 2 diabetic patients. Diabetes Res Clin Pract 2010, 87:233-239. 10.1016/j.diabres.2009.10.017, 19931932.
6. Wu S, Li Y, Jin C, Yang P, Li D, Li H, Shen C. Intra-individual variability of high-sensitivity C-reactive protein in Chinese general population. Int J Cardiol 2011, , http://www.sciencedirect.com/science/article/pii/S0167527310010600
7. Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events: a metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 year. Diabetes Care 1999, 22:233-240. 10.2337/diacare.22.2.233, 10333939.
8. Devaraj S, Venugopal SK, Singh U, Jialal I. Hyperglycemia induces monocytic release of interleukin-6 via induction of protein kinase c-{alpha} and -{beta}. Diabetes 2005, 54:85-91. 10.2337/diabetes.54.1.85, 15616014.
9. Santos AC, Lopes C, Guimarães JT, Barros H. Central obesity as a major determinant of increased high-sensitivity C-reactive protein in metabolic syndrome. Int J Obes (Lond) 2005, 29:1452-1456.
10. Aronson D, Bartha P, Zinder O, Kerner A, Shitman E, Markiewicz W, Brook GJ, Levy Y. Association between fasting glucose and C-reactive protein in middle-aged subjects. Diabet Med 2004, 21:39-44. 10.1046/j.1464-5491.2003.01084.x, 14706052.
11. Nakanishi N, Shiraishi T, Wada M. Association between fasting glucose and C-reactive protein in a Japanese population: the Minoh study. Diabetes Res Clin Pract 2005, 69:88-98. 10.1016/j.diabres.2004.11.009, 15955391.
12. Rhee EJ, Kim YC, Lee WY, Jung CH, Sung KC, Ryu SH, Oh KW, Kim SW. Comparison of insulin resistance and serum high-sensitivity C-reactive protein levels according to the fasting blood glucose subgroups divided by the newly recommended criteria for fasting hyperglycemia in 10059 healthy Koreans. Metabolism 2006, 55:183-187. 10.1016/j.metabol.2005.08.010, 16423624.
13. Nakanishi N, Shiraishi T, Wada M. C-reactive protein concentration is more strongly related to metabolic syndrome in women than in men: the Minoh Study. Circ J 2005, 69:386-391. 10.1253/circj.69.386, 15791030.
14. Lakoski SG, Cushman M, Criqui M, Rundek T, Blumenthal RS, D'Agostino RB, Herrington DM. Gender and C-reactive protein: data from the Multiethnic Study of Atherosclerosis (MESA) cohort. Am Heart J 2006, 152:593-598. 10.1016/j.ahj.2006.02.015, 16923436.
15. Kawamoto R, Tabara Y, Kohara K, Miki T, Kusunoki T, Takayama S, Abe M, Katoh T, Ohtsuka N. High-sensitivity C-reactive protein and gamma-glutamyl transferase levels are synergistically associated with metabolic syndrome in community-dwelling persons. Cardiovascular Diabetology 2010, 9:87. 10.1186/1475-2840-9-87, 3014885, 21143879.
16. Choi KM, Lee J, Lee KW, Seo JA, Oh JH, Kim SG, Kim NH, Choi DS, Baik SH. Comparison of serum concentrations of C-reactive protein, TNF-alpha, and interleukin 6 between elderly Korean women with normal and impaired glucose tolerance. Diabetes Res Clin Pract 2004, 64:99-106. 10.1016/j.diabres.2003.10.007, 15063602.
17. Lu B, Yang Y, Yang Z, Feng X, Wang X, Zhang Z, Hu R. Insulin resistance in Chinese patients with type 2 diabetes is associated with C-reactive protein independent of abdominal obesity. Cardiovasc Diabetol 2010, 9:92. 10.1186/1475-2840-9-92, 3020174, 21167068.
18. Unek IT, Bayraktar F, Solmaz D, Ellidokuz H, Sisman AR, Yuksel F, Yesil S. The levels of soluble CD40 ligand and C-reactive protein in normal weight, overweight and obese people. Clin Med Res 2010, 8:89-95. 10.3121/cmr.2010.889, 2910107, 20660932.
19. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999, 282:2131-2135. 10.1001/jama.282.22.2131, 10591334.
20. Hancu N, Netea MG, Baciu I. High glucose concentrations increase the tumor necrosis factor-alpha production capacity by human peripheral blood mononuclear cells. Rom J Physiol 1998, 35:325-330.
21. Morohoshi M, Fujisawa K, Uchimura I, Numano F. Glucose-dependent interleukin 6 and tumor necrosis factor production by human peripheral blood monocytes in vitro. Diabetes 1996, 45:954-959. 10.2337/diabetes.45.7.954, 8666148.
22. Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M, Quagliaro L, Ceriello A, Giugliano D. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 2002, 106:2067-2072. 10.1161/01.CIR.0000034509.14906.AE, 12379575.
23. Konukoglu D, Hatemi H, Bayer H, Baǧriaçik N. Relationship between serum concentrations of interleukin-6 and tumor necrosis factor alpha in female Turkish subjects with normal and impaired glucose tolerance. Horm Metab Res 2006, 38:34-37. 10.1055/s-2006-924974, 16477538.
24. Yanchun Li Y, Devadoss J, Samuvel DJ, Kamala P, Sundararaj KP, Maria F, Lopes-Virella MF, Huang Y. IL-6 and high glucose synergistically upregulate MMP-1 expression by U937 mononuclear phagocytes via ERK1/2 and JNK pathways and c-Jun. Journal of Cellular Biochemistry 2010, 110:248-259. 2858773, 20225236.
25. Thorand B, Lowel H, Schneider A, Kolb H, Meisinger C, Frohlich M, Koenig W. C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg cohort study, 1984-1998. Arch Intern Med 2003, 163:93-99. 10.1001/archinte.163.1.93, 12523922.
26. Fain JN. Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam Horm 2006, 74:443-477.
27. Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 2001, 280:E745-751.
28. Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 2001, 280:E745-751.
29. Carey AL, Bruce CR, Sacchetti M, Anderson MJ, Olsen DB, Saltin B, Hawley JA, Febbraio MA. Interleukin-6 and tumor necrosis factor-alpha are not increased in patients with Type 2 diabetes: evidence that plasma interleukin-6 is related to fat mass and not insulin responsiveness. Diabetologia 2004, 47:1029-1037.
30. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001, 7:941-946. 10.1038/90984, 11479627.
31. Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ, Retzlaff BM, Knopp RH, Brunzell JD, Kahn SE. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 2003, 46:459-469.
32. You T, Yang R, Lyles MF, Gong D, Nicklas BJ. Abdominal adipose tissue cytokine gene expression: relationship to obesity and metabolic risk factors. Am J Physiol 2005, 288:E741-E747.
33. Thorand B, Baumert J, Kolb H, Meisinger C, Chambless L, Koenig W, Herder C. Sex differences in the prediction of type 2 diabetes by inflammatory markers: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002. Diabetes Care 2007, 30:854-860. 10.2337/dc06-1693, 17392546.
34. Ding EL, Song Y, Malik VS, Liu S. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2006, 295:1288-1299. 10.1001/jama.295.11.1288, 16537739.
35. Rutter MK, Meigs JB, Sullivan LM, D'Agostino RB, Wilson PW. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation 2004, 110:380-385. 10.1161/01.CIR.0000136581.59584.0E, 15262834.